Archives

img-01

Update: China’s Healthcare Privacy Laws

China is trying to make the transfer of personal healthcare data out of China more regulated and formal. Unlike other Asian markets, tissue and blood samples cannot be sent outside of China for analysis. However, personal healthcare data can be sent overseas... Read More

img-01

China to Do More Pharmaceutical Inspections

As drug registration applications grow dramatically in China, so will the CDE audits of drug manufacturing facilities according to the Center for Drug Evaluation (CDE). Earlier this year, the CDE set up a 3-tier system for audits of drug factories including low,... Read More

img-01

Hainan Island New Device Release Increases Gateway To China

On April 22, the NMPA‘s Center for Medical Device Evaluation (CMDE) and the Hainan Medical Product Administration (MPA) announced the Hainan Communication Standard Operating Procedure (SOP) for Medical Device Clinical Real-World Data Applications. This announcement details the regulatory process to register non-approved... Read More

img-01

Digital Healthcare Continues To Grow In Asia

Digital healthcare trends are flourishing in Asia due to its aging population, shortage of healthcare personnel, increasing consumer demand, and technological innovation. According to statistics from Graphical Research, the digital health market in Asia Pacific is expected to grow by 33% from 2020... Read More